Cutaneous inflammatory diseases such as psoriasis vulgaris and atopic dermatitis are associated with altered keratinocyte function, as well as with a particular cytokine production profile of skin-infiltrating T lymphocytes. In this study we show that normal human epidermal keratinocytes express a functional type II oncostatin-M (OSM) receptor (OSMR) consisting of the gp130 and OSMRβ components, but not the type I OSMR. The type II OSMR is expressed in skin lesions from both psoriatic patients and those with atopic dermatitis. Its ligand, OSM, induces via the recruitment of the STAT3 and MAP kinase pathways a gene expression profile in primary keratinocytes and in a reconstituted epidermis that is characteristic of proinflammatory and innate immune responses. Moreover, OSM is a potent stimulator of keratinocyte migration in vitro and increases the thickness of a reconstituted epidermis. OSM transcripts are enhanced in both psoriatic and atopic dermatitic skin as compared with healthy skin and mirror the enhanced production of OSM by T cells isolated from diseased lesions. Results from a microarray analysis comparing the gene-modulating effects of OSM with those of 33 different cytokines indicate that OSM is a potent keratinocyte activator similar to TNF-α, IL-1, IL-17, and IL-22 and that it acts in synergy with the latter cytokines in the induction of S100A7 and β-defensin 2 expression, characteristic of psoriatic skin. Taken together, these results demonstrate that OSM and its receptor play an important role in cutaneous inflammatory responses in general and that the specific effects of OSM are associated with distinct inflammatory diseases depending on the cytokine environment.
Decamethylcyclopentasiloxane (D) is a cyclic volatile methyl siloxane (cVMS) that is widely used in consumer products and commonly observed in urban air. This study quantifies the ambient mixing ratios of D from ground sites in two North American cities (Boulder, CO, USA, and Toronto, ON, CA). From these data, we estimate the diurnal emission profile of D in Boulder, CO. Ambient mixing ratios were consistent with those measured at other urban locations; however, the diurnal pattern exhibited similarities with those of traffic-related compounds such as benzene. Mobile measurements and vehicle experiments demonstrate that emissions of D from personal care products are coincident in time and place with emissions of benzene from motor vehicles. During peak commuter times, the D/benzene ratio (w/w) is in excess of 0.3, suggesting that the mass emission rate of D from personal care product usage is comparable to that of benzene due to traffic. The diurnal emission pattern of D is estimated using the measured D/benzene ratio and inventory estimates of benzene emission rates in Boulder. The hourly D emission rate is observed to peak between 6:00 and 7:00 AM and subsequently follow an exponential decay with a time constant of 9.2 h. This profile could be used by models to constrain temporal emission patterns of personal care products.
Abstract. We describe here characterization of a new stateof-the-art smog chamber facility for studying atmospheric gas-phase and aerosol chemistry. The chamber consists of a 30 m 3 fluorinated ethylene propylene (FEP) Teflon film reactor housed in a temperature-controlled enclosure equipped with black lamps as the light source. Temperature can be set in the range from −10 to 40 • C at accuracy of ±1 • C as measured by eight temperature sensors inside the enclosure and one just inside the reactor. Matrix air can be purified with non-methane hydrocarbons (NMHCs) < 0.5 ppb, NO x /O 3 /carbonyls < 1 ppb and particles < 1 cm −3 . The photolysis rate of NO 2 is adjustable between 0 and 0.49 min −1 . At 298 K under dry conditions, the average wall loss rates of NO, NO 2 and O 3 were measured to be 1.41 × 10 −4 min −1 , 1.39 × 10 −4 min −1 and 1.31 × 10 −4 min −1 , respectively, and the particle number wall loss rate was measured to be 0.17 h −1 . Auxiliary mechanisms of this chamber are determined and included in the Master Chemical Mechanism to evaluate and model propene-NO x -air irradiation experiments. The results indicate that this new smog chamber can provide high-quality data for mechanism evaluation. Results of α-pinene dark ozonolysis experiments revealed secondary organic aerosol (SOA) yields comparable to those from other chamber studies, and the two-product model gives a good fit for the yield data obtained in this work. Characterization experiments demonstrate that our Guangzhou Institute of Geochemistry, Chinese Academy Sciences (GIG-CAS), smog chamber facility can be used to provide valuable data for gas-phase chemistry and secondary aerosol formation.
In this study, we evaluated photosensitized chemistry at the air–sea interface as a source of secondary organic aerosols (SOA). Our results show that, in addition to biogenic emissions, abiotic processes could also be important in the marine boundary layer. Photosensitized production of marine secondary organic aerosol was studied in a custom-built multiphase atmospheric simulation chamber. The experimental chamber contained water, humic acid (1–10 mg L–1) as a proxy for dissolved organic matter, and nonanoic acid (0.1–10 mM), a fatty acid proxy which formed an organic film at the air–water interface. Dark secondary reaction with ozone after illumination resulted in SOA particle concentrations in excess of 1000 cm–3, illustrating the production of unsaturated compounds by chemical reactions at the air–water interface. SOA numbers via photosensitization alone and in the absence of ozone did not exceed background levels. From these results, we derived a dependence of SOA numbers on nonanoic acid surface coverage and dissolved organic matter concentration. We present a discussion on the potential role of the air–sea interface in the production of atmospheric organic aerosol from photosensitized origins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.